The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)

Completed

Phase 4 Results N/A

Summary of Purpose

The purpose of this study is to investigate the Safety and Efficacy of Cilostazol in slowing down the progression of peripheral arterial disease (PAD) in ischemic stroke patients with PAD in Taiwan.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 September 2013.

1 Sep 2010 23 Aug 2010 1 Jul 2013 1 Jul 2013 1 Jul 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Chung Y. Hsu, MD. Ph.D.